Patents by Inventor Claes Post

Claes Post has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use Of Secretagogue For The Teatment Of Ghrelin Deficiency
    Publication number: 20080171700
    Abstract: The present invention relates to the use of a growth hormone (GH) secretagogue, such as a ghrelin-like compound, for the preparation of a medicament for the prophylaxis or treatment of ghrelin deficiency, and/or undesirable symptoms associated therewith, in an individual at risk of acquiring partial or complete ghrelin deficiency resulting from a medical treatment and/or from a pathological condition. The present invention also relates to use of a secretagogue compound for the preparation of a medicament for the prophylaxis or treatment of one or more of: loss of fat mass, loss of lean body mass, weight loss, cachexia, loss of appetite, immunological dysfunction, malnutrition, disrupted sleep pattern, sleepiness, reduction in intestinal absorption and/or intestinal mobility problems in an individual suffering from, or at risk of suffering from, ghrelin deficiency.
    Type: Application
    Filed: April 7, 2005
    Publication date: July 17, 2008
    Applicant: Gastrotech Pharma A/S
    Inventors: Henrik Nilsson, Birgitte Holst Lange, Claes Post, Tina Geritz Nielsen
  • Alpha-aminoamide derivatives useful as analgesic agents
    Patent number: 6306903
    Abstract: The present invention relates to novel and known alpha-aminoamide compounds, to a process for their preparation, to pharmaceutical composition containing them and to their use as therapeutic agents. In particular, the compounds of the present invention are endowed with analgesic properties and are particularly useful for the treatment and alleviation of chronic and neuropathic pain.
    Type: Grant
    Filed: August 29, 2000
    Date of Patent: October 23, 2001
    Assignee: Newron Pharmaceuticals S.p.A.
    Inventors: Paolo Pevarello, Mario Varasi, Patricia Salvati, Claes Post
  • Substituted 2-benzylamino-2-phenyl-acetamide compounds
    Patent number: 6303819
    Abstract: Compounds which are substituted 2-benzylamino-2-phenyl-acetamide compounds of formula (I) wherein: n is zero, 1, 2 or 3; X is —O—, —S—, —CH2— or —NH—; each of R, R1, R2 and R3, independently, is hydrogen, C1-C6 alkyl, halogen, hydroxy, C1-C6 alkoxy or trifluoromethyl; each of R4 and R5, independently, is hydrogen, C1-C6 alkyl or C3-C7 cycloalkyl; or pharmaceutically acceptable salts thereof, are useful in treating conditions such as chronic or neuropathic pain.
    Type: Grant
    Filed: September 11, 2000
    Date of Patent: October 16, 2001
    Assignee: Newron Pharmaceuticals S.p.A.
    Inventors: Paolo Pevarello, Mario Varasi, Patricia Salvati, Claes Post
  • Alpha-aminoamide derivatives useful as analgesic agents
    Patent number: RE40259
    Abstract: The present invention relates to novel and known alpha-aminoamide compounds, to a process for their preparation, to pharmaceutical composition containing them and to their use as therapeutic agents. In particular, the compounds of the present invention are endowed with analgesic properties and are particularly useful for the treatment and alleviation of chronic and neuropathic pain.
    Type: Grant
    Filed: December 12, 1998
    Date of Patent: April 22, 2008
    Assignee: Newron Pharmaceuticals, S.p.A.
    Inventors: Paolo Pevarello, Mario Varasi, Patricia Salvati, Claes Post